SEC Comment Letter for Fortress Biotech, Inc. (FBIO, FBIOP) (CIK 0001429260) (FBIO) — Jun 24, 2024
Fortress Biotech, Inc. (FBIO, FBIOP) (CIK 0001429260)
Date: June 24, 2024 · CIK: 0001429260 · Accession: 0000000000-24-007137
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-280342
Letter
United States securities and exchange commission logo June 24, 2024 Lindsay A. Rosenwald Chief Executive Officer Fortress Biotech, Inc. 1111 Kane Concourse, Suite 301 Bay Harbor Islands, FL 33154 Re:Fortress Biotech, Inc. Registration Statement on Form S-3 Filed June 20, 2024 File No. 333-280342 Dear Lindsay A. Rosenwald: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tyler Howes at 202-551-3370 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: David Wolpa, Esq.
Show Raw Text
United States securities and exchange commission logo
June 24, 2024
Lindsay A. Rosenwald
Chief Executive Officer
Fortress Biotech, Inc.
1111 Kane Concourse, Suite 301
Bay Harbor Islands, FL 33154
Re:Fortress Biotech, Inc.
Registration Statement on Form S-3
Filed June 20, 2024
File No. 333-280342
Dear Lindsay A. Rosenwald:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tyler Howes at 202-551-3370 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: David Wolpa, Esq.